Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 474,400 | 489,500 | 502,900 | 430,400 | 382,800 |
| Receivables | 1,589,700 | 1,523,200 | 1,446,300 | 1,380,700 | 1,320,800 |
| Inventories | 1,095,400 | 1,008,400 | 1,001,600 | 986,700 | 949,500 |
| Other current assets | 333,200 | 279,900 | 304,500 | 321,800 | 296,600 |
| TOTAL | $3,492,700 | $3,301,000 | $3,255,300 | $3,119,600 | $2,949,700 |
| Non-Current Assets | |||||
| PPE Net | 2,715,000 | 2,696,100 | 2,526,400 | 2,504,500 | 2,519,600 |
| Intangibles | 2,920,200 | 2,912,900 | 2,884,500 | 2,830,000 | 2,660,900 |
| Other Non-Current Assets | 229,700 | 228,000 | 502,300 | 507,100 | 565,600 |
| TOTAL | $5,864,900 | $5,837,000 | $5,913,200 | $5,841,600 | $5,746,100 |
| Total Assets | $9,357,600 | $9,138,000 | $9,168,500 | $8,961,200 | $8,695,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 787,900 | 776,700 | 271,900 | 270,500 | 135,200 |
| Accounts payable and accrued liabilities | 1,005,200 | 1,039,700 | 915,000 | 872,400 | 851,400 |
| TOTAL | $3,818,900 | $3,469,100 | $2,860,900 | $2,660,200 | $2,663,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,660,600 | 2,720,400 | 3,126,200 | 3,156,000 | 3,201,200 |
| aiOther Non-Current Liabilities | 1,267,300 | 1,227,700 | 1,008,700 | 1,029,100 | 1,002,500 |
| TOTAL | $4,120,900 | $4,258,000 | $4,673,000 | $4,705,500 | $4,744,700 |
| Total Liabilities | $7,939,800 | $7,727,100 | $7,533,900 | $7,365,700 | $7,408,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,022,983 | 1,026,828 | 1,028,640 | 1,032,840 | 1,029,334 |
| Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
| Retained earnings | 9,775,000 | 9,643,700 | 9,422,900 | 9,246,300 | 8,976,200 |
| Other shareholders' equity | -2,278,700 | -2,332,500 | -2,035,800 | -2,059,400 | -2,035,000 |
| TOTAL | $1,417,800 | $1,410,900 | $1,634,600 | $1,595,500 | $1,287,800 |
| Total Liabilities And Equity | $9,357,600 | $9,138,000 | $9,168,500 | $8,961,200 | $8,695,800 |